Press Releases

Sep 09, 2014

20 Years ProBioGen: Invests €20 million in Mammalian Manufacturing Expansion

read more 20 Years ProBioGen: Invests €20 million in Mammalian Manufacturing Expansion

download PDF

Sep 04, 2014

Festakt 20 Jahre ProBioGen

read more Festakt 20 Jahre ProBioGen

download PDF

Jun 23, 2014

ProBioGen signs GlymaxX ADCC Enhancement Technology License Deal with Novartis

read more ProBioGen signs GlymaxX ADCC Enhancement Technology License Deal with Novartis

download PDF

Mar 04, 2014

ProBioGen and Merus Sign Deal on GlymaxX® ADCC Enhancement Technology

read more ProBioGen and Merus Sign Deal on GlymaxX® ADCC Enhancement Technology

download PDF

Dec 17, 2013

ProBioGen Announces Expansion of Commercial Licenses with Emergent BioSolutions for AGE1.CR® Viral Vaccine Manufacturing Production Platform

read more ProBioGen Announces Expansion of Commercial Licenses with Emergent BioSolutions for AGE1.CR® Viral Vaccine Manufacturing Production Platform

download PDF

Oct 30, 2013

ProBioGen Upholds Strong Patent Position in Viral Vaccine Manufacturing Field

read more ProBioGen Upholds Strong Patent Position in Viral Vaccine Manufacturing Field

download PDF

Feb 19, 2013

ProBioGen Signs next GlymaxX® ADCC Technology Deal with TOP 10 Pharma Company for Therapeutic Antibody Platform

read more ProBioGen Signs next GlymaxX® ADCC Technology Deal with TOP 10 Pharma Company for Therapeutic Antibody Platform

download PDF

Nov 12, 2012

ProBioGen Launches Unique Portfolio of Engineered High-Performance Cell Lines for Biopharmaceutical Manufacturing

read more ProBioGen Launches Unique Portfolio of Engineered High-Performance Cell Lines for Biopharmaceutical Manufacturing

download PDF

Jun 14, 2012

ProBioGen Introduces Novel Productivity-Boosting Technology for Therapeutic Protein Production: "Pathway Modulator"

read more ProBioGen Introduces Novel Productivity-Boosting Technology for Therapeutic Protein Production: "Pathway Modulator"

download PDF

Oct 25, 2011

ProBioGen and Inhibrx Sign License Deal on GlymaxX® ADCC Technology for Therapeutic Antibodies Development

read more ProBioGen and Inhibrx Sign License Deal on GlymaxX® ADCC Technology for Therapeutic Antibodies Development

download PDF

Page 8 of 11

ProBioGen News

Join our news and always be up-to-date.

Sign up